NCT02971813 is a NA clinical trial of Facebook in Cardiovascular Diseases, sponsored by The Cleveland Clinic.

Who is sponsoring NCT02971813?

NCT02971813 is sponsored by The Cleveland Clinic.

What drugs are being tested in NCT02971813?

Interventions in NCT02971813: Facebook.

What condition does NCT02971813 study?

NCT02971813 studies Cardiovascular Diseases.

Is NCT02971813 still recruiting?

NCT02971813 is currently completed. Last updated 27 March 2020.

Last reviewed 2020-03-27 · How we verify

NCT02971813

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Social Media Intervention for Exercise Motivation and Cardiac Rehabilitation Adherence

Completed NA Last updated 27 March 2020

What this trial tests

NA trial testing Facebook in Cardiovascular Diseases in 22 participants. Completed in 1 March 2019.

Timeline

27 February 2017

Primary endpoint
28 February 2019

1 March 2019

Quick facts

Lead sponsor	The Cleveland Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	22
Start date	27 February 2017
Primary completion	28 February 2019
Estimated completion	1 March 2019
Sites	1 location across United States

Drugs / interventions tested

Facebook

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

While cardiac rehabilitation (CR) has been shown to be effective at improving cardiovascular disease (CVD), participation is generally poor. The current feasibility study, will evaluate the impact of a social media intervention on motivation for exercise and adherence to CR sessions. Participants will be randomly assigned to a Facebook™ group or an enhanced education comparison group. The intervention will include access to a private Facebook™ group in which participants will receive weekly educational posts, weekly provider support and have the opportunity to communicate with other cardiac rehabilitation patients. Patients in the comparison group will be given the same educational materials, but these will be supplied in email. Participants will be asked to fill out a pre-post motivational questionnaire and the total number of sessions attended at the end of 3 months will be tallied. This study is grounded in Self-Determination Theory (SDT) and utilizes the Behavioral Regulation in Exercise Questionnaire (BREQ-2), which is based on the SDT.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Feasibility of a Facebook Intervention for Exercise Motivation and Cardiac Rehabilitation Adherence: Study Protocol.
Siegmund LA, Ahmed HM, Crawford MT, Bena JF. · · 2017 · cited 13× · PMID 28821473 · DOI 10.2196/resprot.7554
Cardiac Rehabilitation Facebook Intervention: Feasibility Randomized Controlled Trial.
Siegmund LA, Bena JF, Morrison SL. · · 2023 · PMID 37318865 · DOI 10.2196/46828

Verify or expand the search:

Other trials of Facebook

Trials testing the same drug.

NCT02929108 — ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making) · NA · completed
NCT02717403 — Effects of Social Networking on Chronic Disease Management in Arthritis · Phase 2, PHASE3 · completed

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other The Cleveland Clinic trials

Trials by the same sponsor.

NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
NCT07442747 — Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS · NA · not yet recruiting
NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07363343 — Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02971813 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cleveland Clinic
Last refreshed: 27 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02971813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing